A double-blind, double-dummy, randomized, placebo- and active-controlled, three-way crossover study to evaluate the effect of Budesonide/Formoterol Spiromax 80/4.5 mcg Inhalation Powder and Symbicort Turbohaler 100/6 mcg on the short-term lower leg growth rate in prepubescent children with persistent asthma.
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2012
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 05 Sep 2012 Results presented at the 22nd Annual Congress of the European Respiratory Society.
- 22 Mar 2012 Additional trial location added as reported by European Clinical Trials Database,
- 22 Jun 2011 New trial record